<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="
The company added that the results, issued today, Sunday, showed that the drug improved respiratory symptoms andfever disease caused.
She indicated that the drug was taken, during clinical trials, orally once a day for five days.
The company hopes that the experimental treatment, which is in the form of tablets, will achieve global spread after obtaining the approval of the regulatory authorities in the country Japanwhich you are currently checking.
And she was "shinoji" Last March, it revealed that it will launch the third phase of clinical trials for the treatment globally, with the support of US government.
Isao Techirogi, President and CEO of the company, said: "We look forward to continuing the study and testing of this antiviral drug in phase 3 trials".
“>
The company added that the results, issued today, Sunday, showed that the drug improved respiratory symptoms andfever disease caused.
She indicated that the drug was taken, during clinical trials, orally once a day for five days.
The company hopes that the experimental treatment, which is in the form of tablets, will achieve global spread after obtaining the approval of the regulatory authorities in the country Japanwhich you are currently checking.
And “Shionouji” had revealed, last March, that it would launch the third phase of clinical trials for the treatment globally, with the support of… US government.
“We look forward to continuing the study and testing of this antiviral drug in Phase III trials,” said Isao Techirugi, the company’s president and CEO.